About Us

What We Do

We help small and/or emerging life science companies in their efforts to expand distribution throughout the US market via our Advisory and Consulting Services. We also assist clients with their launch messaging and positioning for success while attaining or surpassing commercial expectations.
All services have been crafted to support and elevate sales, marketing & the commercialization of our client’s healthcare products and services through a proven process that is efficient, affordable, sustainable, and ultimately results in commercial success. Our services and approach are methodical, easy to incorporate, metric based, resulting in an effective Go to Market (GTM) platform.
We seek both domestic & international expansion engagements including commercial growth opportunities from partners in: England, Scotland, Germany, France, Singapore, Japan, Switzerland, Australia, Norway, Spain, Italy and of course the US itself. Creating and facilitating an active ecosystem between these countries and the US is our objective. We are a conduit for life science firms that want to grow by selling their products or services in the US market…that is what we do.

What You Receive

C-level and mid-management support (director and up) in development of their revenue Go Forward…plan reviews and refinement, plan development, professional mentorship, and other foundational efforts based on the specific needs of the client.
Collaborative development of revenue architecture including marcom, sales processes, sales operations, pipeline structure, tracking and reporting on predetermined revenue centric efforts.
Participation in specific corporate meetings, prospect meetings, board meetings, and any additional meetings that will advance a clients opportunity to expand in the US life science market.
Lead, mentor, train, support, facilitate, and other things TBD for client’s sales operations, marketing operations, and commercialization fulfillment.

OUR IMPACT / DELIVERABLES

Increased Revenue & Profitability (6-9 months).
CIP – TOMA (ongoing).
Elevated brand equity.
Shortened sales cycles.
Effective and efficient sales process development and oversight (ongoing).
Expanded reach and frequency of corporate prospect facing UCB (unique compelling benefits / value prop).
Continually active and evolving GTM sales strategies and market positioning tactics.